Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.056,689,292,75,
%Companies according to biotechnology used: Genetic code,36,44,18,30,
%Companies according to biotechnology used: Functional units,45,50,38,20,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,27,32,17,26,
%Companies according to biotechnology used: Bioprocesses,47,39,69,30,
%Companies according to biotechnology used: Sub-cellular organisms,8,11,4,0,
%Companies according to biotechnology used: Bio-computing,25,33,10,8,
%Companies according to biotechnology used: Nanobiotechnology,13,17,8,1,
%Companies according to biotechnology used: Other,15,15,12,32,
Companies in which biotechnology activities are: Main and/or exclusive,551,467,71,12,
Companies in which biotechnology activities are: A secondary line of business,183,108,64,11,
Companies in which biotechnology activities are: A tool necessary for production,323,114,157,53,
%Company by field(s) of ultimate application of biotechnology use: Human Health,49,63,28,1,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,20,22,13,29,
%Company by field(s) of ultimate application of biotechnology use: Food products,30,25,48,15,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,20,18,66,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,12,17,7,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,14,12,0,
Personnel in R&D in biotechnology (no. of persons),10.719,7.222,2.881,616,
Personnel in R&D in biotechnology (no. of persons): Researchers,6.131,4.585,1.339,207,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.588,2.637,1.542,409,
Personnel in R&D in biotechnology (no. of persons): women,6.040,4.276,1.472,292,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.411,2.569,737,104,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.629,1.706,735,188,
Personnel in R&D in biotechnology (FTE),7.750,8,5.437,6,1.946,7,366,5,
Personnel in R&D in biotechnology (FTE): Researchers,4.518,1,3.435,2,944,9,138,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.232,7,2.002,4,1.001,7,228,6,
Personnel in R&D in biotechnology (FTE): women,4.471,4,3.236,6,1.044,4,190,4,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.562,7,1.944,546,7,72,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.908,7,1.292,6,497,7,118,4,
Internal expenditure on R&D (thousands of euros),679.558,485.966,166.743,26.849,
1) By nature of the expense: Current expenses,634.631,450.150,159.316,25.166,
1.1) Remuneration to researchers,228.857,161.501,60.869,6.486,
1.2) Remuneration to technicians and assistants,104.498,57.591,40.473,6.434,
1.3) Other current expenses,301.276,231.058,57.973,12.245,
2) By nature of the expense: Capital expenses,44.927,35.816,7.427,1.683,
2.1) Land and buildings,2.585,1.409,1.078,98,
2.2) Equipment and instruments,23.569,17.290,4.766,1.513,
2.3) Acquisition of specific R&D software,1.392,1.193,196,3,
2.4) Otros productos de propiedad intelectual específicos para I+D,17.381,15.923,1.388,70,
1) By origin of the funds: National funds,556.297,390.804,140.672,24.820,
1.1) Own funds,387.010,235.228,128.729,23.053,
1.2) From companies,86.025,81.958,4.067,0,
1.3) Public Administration funds,74.764,65.121,7.876,1.767,
1.4) From Universities,408,408,0,0,
1.5) From non profit private institutions,8.090,8.090,0,0,
1) By origin of the funds: Foreign funds,123.262,95.161,26.071,2.029,
2.1) From EU programmes,25.125,22.065,2.915,145,
2.2) Other foreign funds,98.137,73.097,23.156,1.884,
Purchase of R&D services in biotechnology (thousands of euros),147.558,85.114,61.830,614,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,76.875,25.665,50.761,450,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,70.683,59.449,11.070,165,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,49,58,30,33,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,14,13,13,23,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,16,14,30,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,13,16,9,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,18,21,11,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,18,21,10,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,17,18,16,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,40,34,28,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,51,54,44,50,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,19,13,22,
% Companies that have requested biotechnology patents in Biotechnology,16,19,9,4,
Number of patents requested,746,591,120,34,
% Companies with income of an international origin related to biotechnological activities,23,3,27,7,17,3,5,7,
% Turnover representing income of an international origin related to biotechnological activities,1,2,3,1,1,0,6,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,60,4,54,5,61,2,100,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,39,6,45,5,38,8,.,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,80,9,77,9,81,3,100,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,17,8,15,5,18,4,.,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,3,6,4,0,4,.,
% Income of an international origin related with activities according to the classification: Other,0,1,0,2,0,.,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute